Log in to save to my catalogue

A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltrat...

A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltrat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_16432509

A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats

About this item

Full title

A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats

Publisher

England

Journal title

British journal of pharmacology, 2006-03, Vol.147 (6), p.661

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

alpha(4)beta(1) and alpha(4)beta(7) integrins are preferentially expressed on eosinophils and mononuclear leukocytes and play critical roles in their recruitment to inflammatory sites. We investigated the effects of TR14035, a small molecule, alpha(4)beta(1)/alpha(4)beta(7) dual antagonist, in a rat model of allergic asthma. Actively sensitized rat...

Alternative Titles

Full title

A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_16432509

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_16432509

Other Identifiers

ISSN

0007-1188

How to access this item